Medicine & Life Sciences
MPT0L145
100%
Histone Deacetylase Inhibitors
95%
3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide
71%
Autophagy
44%
Pharmaceutical Chemistry
42%
Urinary Bladder Neoplasms
40%
Neoplasms
40%
In Vitro Techniques
39%
1,2,3,4-tetrahydroquinoline
38%
5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzimidazol-5-yl)pyrimidin-2-yl)amine
37%
Anilides
36%
Benzamides
34%
Cell Death
31%
Microtubules
29%
Apoptosis
29%
Histone Deacetylases
29%
Growth
28%
Prostatic Neoplasms
27%
3-((6-((5-benzylidene-3,6-dioxopiperazin-2-ylidene)methyl)pyridin-3-yloxy)methyl)benzoic acid
26%
Colorectal Neoplasms
24%
Histones
24%
Herbal Medicine
22%
Acrylamide
22%
Pyrrolo(2,3-d)pyrimidine
22%
Drug Development
21%
Antineoplastic Agents
21%
trichlorobenzene
21%
Down-Regulation
20%
Tomatine
20%
Lung Neoplasms
20%
Pharmacy
20%
Taiwan
20%
3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione
20%
Emotions
20%
protopine
19%
Kruppel-Like Factor 6
18%
Inhibitory Concentration 50
17%
Vorinostat
17%
Pharmaceutical Preparations
17%
Cell Cycle
16%
Mendelian Randomization Analysis
16%
Therapeutics
15%
Heterografts
15%
Ligands
15%
Phosphorylation
15%
Lysine
13%
Cadherins
13%
Lovastatin
13%
HSP90 Heat-Shock Proteins
13%
Chemical Compounds
Anilide
26%
Histone
26%
50 Percent Growth Inhibition
18%
Antineoplastic Agent
18%
Chemistry
17%
Vorinostat
17%
Drug
16%
Propidium
16%
Glyphosate
14%
Inhibition of Growth
13%
Antiproliferative
12%
Protein
12%
Acrylamide
11%
Membrane Potential
11%
Thrombin
10%
Cell Death
10%
Dose
10%
Ring Formation
10%
Cell Viability
10%
Vincristine
10%
Immunoassay
9%
Liquid Crystal
9%
Etoposide
9%
Pyrimidine
9%
Antigen
8%
Microextraction
7%
Needle Like Crystal
7%
Antimicrobial Agent
7%
Mass Spectrometry
6%
Solubility
6%
Resistance
6%
Modification
5%
Weight
5%